Cas 1448610-06-7,5-[4-[1-cyclopropyl-1-[5-(1H-pyrazol-4-yl)thiazol-2-yl]ethyl]phenyl]pyrimidin-2-amine

1448610-06-7

Post Buying Request

Basic information

Product Name: 5-[4-[1-cyclopropyl-1-[5-(1H-pyrazol-4-yl)thiazol-2-yl]ethyl]phenyl]pyrimidin-2-amine
Synonyms: 5-[4-[1-cyclopropyl-1-[5-(1H-pyrazol-4-yl)thiazol-2-yl]ethyl]phenyl]pyrimidin-2-amine
CAS NO:1448610-06-7
Molecular Formula:
Molecular Weight: 388.496
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 5-[4-[1-cyclopropyl-1-[5-(1H-pyrazol-4-yl)thiazol-2-yl]ethyl]phenyl]pyrimidin-2-amine(CAS DataBase Reference)
NIST Chemistry Reference: 5-[4-[1-cyclopropyl-1-[5-(1H-pyrazol-4-yl)thiazol-2-yl]ethyl]phenyl]pyrimidin-2-amine(1448610-06-7)
EPA Substance Registry System: 5-[4-[1-cyclopropyl-1-[5-(1H-pyrazol-4-yl)thiazol-2-yl]ethyl]phenyl]pyrimidin-2-amine(1448610-06-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1448610-06-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1448610-06-7 Suppliers

Recommended suppliers

1448610-06-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1448610-06-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,4,8,6,1 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1448610-06:
(9*1)+(8*4)+(7*4)+(6*8)+(5*6)+(4*1)+(3*0)+(2*0)+(1*6)=157
157 % 10 = 7
So 1448610-06-7 is a valid CAS Registry Number.

1448610-06-7Upstream product

1448610-06-7Downstream Products

1448610-06-7Relevant academic research and scientific papers

HETEROCYCLIC COMPOUNDS AS INHIBITORS OF LEUKOTRIENE PRODUCTION

-

Paragraph 0383; 0384; 0396, (2013/08/14)

The present invention relates to compound of formula (I): or pharmaceutically acceptable salts thereof, wherein R1-R7, A and HET are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1448610-06-7